- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Wayne Jonas Discusses the Role of Integrative Health in Treating Pain
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses how integrative health practices can help treat patients with pain.
Transcript
What role does integrative health play in helping patients manage pain?
So, I that's a great question. And I would say that the short answer is that integrative health practices and nonpharmacological approaches for chronic pain have a central role. All you have to do is look at the current national guidelines from almost anywhere—the American College of Physicians, the CDC, the NIH [National Institute of Health], JCAHO [Joint Commission on Accreditation of Healthcare Organizations]—they all recommend that non pharmacological approaches and be integrated with standard conventional drug approaches for the treatment of chronic pain. And in fact, many of them say that for many chronic conditions, they should be the lead approach for chronic pain.
And so, I think that it's imperative for anybody that deals with people with chronic pain—And that's a lot of people. There's 100 million people in the country that suffer with chronic pain—that they learn these skills and they make them a part of their standard practice.
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”
February 7th 2025Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.
Read More
